This study is not yet accepting patients
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Summary
- Location
- at Irvine, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Novo Nordisk A/S
- ID
- NCT06609226
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 325 study participants
- Last Updated